In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches
Michail S. Kukharsky, Veronika Skvortsova, С. О. Бачурин, Vladimir L. Buchman
Abstract
Recent progress in understanding the pathological changes in the nervous system and in certain other body systems (e.g., immune system) that lead to the development and progression of amyotrophic lateral sclerosis (ALS) revealed a number of molecular and cellular processes that can potentially be used as therapeutic targets. Many of these processes are compromised not only in ALS but also in other diseases and a repertoire of drugs able to restore, at least partially, their functionality has been developed. In this review, we briefly describe current approaches to the repurposing of such "old" drugs for treatment of patients with ALS.
Topics & Concepts
Amyotrophic lateral sclerosisDrug repositioningMedicineRepurposingNeuroscienceImmune systemMultiple sclerosisCentral nervous systemDrugBioinformaticsBiologyDiseasePharmacologyImmunologyPathologyEcologyAmyotrophic Lateral Sclerosis ResearchCholinesterase and Neurodegenerative DiseasesHistone Deacetylase Inhibitors Research